APA |
Karakaya, O. ., Esen, A. M. ., Barucu, İ. ., Saglam, M. ., et al. (2004). In-Stent Restenosis and Drug-Eluting Stents. Koşuyolu Kalp Dergisi, 8(2), 12-27. |
|
AMA |
Karakaya O, Esen AM, Barucu İ, Saglam M, Ozdemir N, Kaymaz C. In-Stent Restenosis and Drug-Eluting Stents. Koşuyolu Kalp Dergisi. February 2004;8(2):12-27. |
|
Chicago |
Karakaya, Osman, Ali Metin Esen, İrfan Barucu, Mustafa Saglam, Nihal Ozdemir, and Cihangir Kaymaz. “In-Stent Restenosis and Drug-Eluting Stents”. Koşuyolu Kalp Dergisi 8, no. 2 (February 2004): 12-27. |
|
EndNote |
Karakaya O, Esen AM, Barucu İ, Saglam M, Ozdemir N, Kaymaz C (February 1, 2004) In-Stent Restenosis and Drug-Eluting Stents. Koşuyolu Kalp Dergisi 8 2 12–27. |
|
IEEE |
O. . Karakaya, A. M. . Esen, İ. . Barucu, M. . Saglam, N. . Ozdemir, and C. . Kaymaz, “In-Stent Restenosis and Drug-Eluting Stents”, Koşuyolu Kalp Dergisi, vol. 8, no. 2, pp. 12–27, 2004. |
|
ISNAD |
Karakaya, Osman et al. “In-Stent Restenosis and Drug-Eluting Stents”. Koşuyolu Kalp Dergisi 8/2 (February 2004), 12-27. |
|
JAMA |
Karakaya O, Esen AM, Barucu İ, Saglam M, Ozdemir N, Kaymaz C. In-Stent Restenosis and Drug-Eluting Stents. Koşuyolu Kalp Dergisi. 2004;8:12–27. |
|
MLA |
Karakaya, Osman et al. “In-Stent Restenosis and Drug-Eluting Stents”. Koşuyolu Kalp Dergisi, vol. 8, no. 2, 2004, pp. 12-27. |
|
Vancouver |
Karakaya O, Esen AM, Barucu İ, Saglam M, Ozdemir N, Kaymaz C. In-Stent Restenosis and Drug-Eluting Stents. Koşuyolu Kalp Dergisi. 2004;8(2):12-27. |
|